Treatments - Medika Life

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Health Innovation Has a Friction Problem

India: The Growing Focal Point for Health Innovation

Jackie Kennedy and Jane Fonda — Same Diagnosis, Different Decades and Treatments

Ivermectin is Dead and Buried Despite NIH Website Misstep and Twitter Buzz

LATEST

TRENDING

Jackie Kennedy and Jane Fonda — Same Diagnosis, Different Decades and Treatments

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Ivermectin is Dead and Buried Despite NIH Website Misstep and Twitter Buzz

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

Is mRNA Technology the New Penicillin?

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

Artificial Intelligence Company Helps IVF Patients Get Pregnant

FDA Approval of New Drug for Alzheimer’s Offers Hope

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

Artificial Intelligence Company Helps IVF Patients Get Pregnant

Oxycodone No Better in Treating Post-Orthopedic Surgical Pain

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories